Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,891,528
  • Shares Outstanding, K 51,136
  • Annual Sales, $ 4,050 M
  • Annual Income, $ 22,200 K
  • EBIT $ 581 M
  • EBITDA $ 1,158 M
  • 60-Month Beta 1.45
  • Price/Sales 2.23
  • Price/Cash Flow 8.15
  • Price/Book 2.61

Options Overview Details

View History
  • Implied Volatility 38.06% ( -0.30%)
  • Historical Volatility 39.20%
  • IV Percentile 54%
  • IV Rank 40.81%
  • IV High 53.90% on 10/30/24
  • IV Low 27.14% on 08/16/24
  • Put/Call Vol Ratio 3.67
  • Today's Volume 28
  • Volume Avg (30-Day) 226
  • Put/Call OI Ratio 1.43
  • Today's Open Interest 6,453
  • Open Int (30-Day) 6,219

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.06
  • Number of Estimates 8
  • High Estimate 2.10
  • Low Estimate 2.04
  • Prior Year 2.27
  • Growth Rate Est. (year over year) -9.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
161.30 +3.82%
on 02/21/25
181.44 -7.70%
on 03/10/25
+5.21 (+3.21%)
since 02/20/25
3-Month
150.79 +11.06%
on 02/12/25
193.56 -13.48%
on 01/07/25
-18.31 (-9.85%)
since 12/20/24
52-Week
150.79 +11.06%
on 02/12/25
274.77 -39.05%
on 03/22/24
-100.71 (-37.55%)
since 03/20/24

Most Recent Stories

More News
3 Reasons CRL is Risky and 1 Stock to Buy Instead

3 Reasons CRL is Risky and 1 Stock to Buy Instead

YUM : 157.56 (+0.03%)
CRL : 168.63 (-3.02%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 9.27 (+0.11%)
UFPT : 215.31 (+0.29%)
AZTA : 37.59 (+2.20%)
WST : 228.65 (-0.76%)
CRL : 168.63 (-3.02%)
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 9.27 (+0.11%)
MEDP : 322.88 (-1.40%)
AZTA : 37.59 (+2.20%)
CRL : 168.63 (-3.02%)
IQV : 186.01 (-0.50%)
Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?

Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance.

XLV : 147.03 (+0.07%)
$SPX : 5,702.44 (+0.48%)
JPM : 240.84 (+0.72%)
CRL : 168.63 (-3.02%)
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

UFPT : 215.31 (+0.29%)
AZTA : 37.59 (+2.20%)
CRL : 168.63 (-3.02%)
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow

Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow

RGEN : 143.45 (-0.99%)
AZTA : 37.59 (+2.20%)
CRL : 168.63 (-3.02%)
Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4

Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4

CRL : 168.63 (-3.02%)
Charles River: Q4 Earnings Snapshot

Charles River: Q4 Earnings Snapshot

CRL : 168.63 (-3.02%)
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow

Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow

AZTA : 37.59 (+2.20%)
CRL : 168.63 (-3.02%)
IQV : 186.01 (-0.50%)
Charles River Laboratories' Quarterly Earnings Preview: What You Need to Know

Charles River Laboratories will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

XLV : 147.03 (+0.07%)
$SPX : 5,702.44 (+0.48%)
CRL : 168.63 (-3.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 183.00
2nd Resistance Point 180.90
1st Resistance Point 177.39
Last Price 168.63
1st Support Level 171.78
2nd Support Level 169.68
3rd Support Level 166.17

See More

52-Week High 274.77
Fibonacci 61.8% 227.41
Fibonacci 50% 212.78
Fibonacci 38.2% 198.15
Last Price 168.63
52-Week Low 150.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar